| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACELYRIN, Inc. | Chief Medical Officer | Common Stock | 0 | $0 | $2.45 | 21 May 2025 | Direct |
| ACELYRIN, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 328,860 | 23 May 2024 | Direct | ||
| ACELYRIN, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 0 | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLRN | ACELYRIN, Inc. | 21 May 2025 | 4 | $0 | 4 | Chief Medical Officer | 23 May 2025, 16:08 |
| SLRN | ACELYRIN, Inc. | 17 Mar 2025 | 1 | -$8,811 | 4 | Chief Medical Officer | 19 Mar 2025, 17:55 |
| SLRN | ACELYRIN, Inc. | 23 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 24 Jan 2025, 18:05 |
| SLRN | ACELYRIN, Inc. | 23 May 2024 | 1 | $0 | 4 | Chief Medical Officer | 24 May 2024, 19:10 |
| SLRN | ACELYRIN, Inc. | 09 May 2024 | 0 | $0 | 3 | Chief Medical Officer | 17 May 2024, 19:08 |